Certara, Inc.
CERT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Společnost Certara, Inc. poskytuje zákazníkům softwarové produkty a služby založené na technologiích pro biosimulaci při vyhledávání léčiv, předklinickém a klinickém výzkumu, regulačních podáních a přístupu na trh. Nabízí léky pacientům používajícím biosimulační software, technologie a služby k transformaci objevování a vývoje léčiv. Společnost také poskytuje související služby s technologiemi, které mají vést nové léky svých zákazníků prostřednictvím procesu předkládání právních předpisů a na trh. Mezi služby, které využívá technologií, patří mechanistická biosimulace, empirická biosimulace, vývoj léků a regulační strategie, klinická farmakologie, metaanalýza založená na modelech, regulační psaní a lékařská komunikace, regulační operace a přístup na trh. Společnost dále nabízí software, který zahrnuje mechanistickou biosimulační platformu, empirickou biosimulační platformu PK/PD, software pro standardizaci a soulad dat, platformu pro vědeckou informatiku, databáze klinických výsledků pro biosimulaci, tvorbu a řízení platformy pro předkládání regulačních údajů a platformu pro komunikaci o přístupu na trh. Společnost slouží biofarmaceutickým společnostem a akademickým a vládním institucím. Působí ve Spojených státech, Kanadě, Španělsku, Lucembursku, Portugalsku, Velké Británii, Německu, Francii, Nizozemsku, Dánsku, Švýcarsku, Itálii, Polsku, Japonsku, na Filipínách, v Indii, Austrálii a Číně. Certara Inc. byla založena v roce 2008 a sídlí v Princetonu v New Jersey.
Sektor
Healthcare
Odvětví
Medical - Healthcare Information Services
Počet zaměstnanců
1487
Založení
2020-12-11
Podobné společnosti
$ 16.56
+ $ 1.31
$ 2.62
- $ 0.05
$ 38.91
- $ 0.03
$ 18.29
+ $ 0.51
$ 23.83
+ $ 1.46
$ 127.45
+ $ 0.28
$ 36.26
+ $ 0.58
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 418.8 | 418.8 | 385.1 | 354.3 | 335.6 | 286.1 | 243.5 | 208.5 | 163.7 | |
| Cost of Revenues | 161.1 | 161.1 | 154.5 | 141.0 | 132.6 | 111.6 | 100.8 | 79.8 | 71.0 | |
| Gross Profit | 257.7 | 257.7 | 230.6 | 213.3 | 203.1 | 174.5 | 142.8 | 128.7 | 92.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 103.6 | 104.6 | 104.6 | 106.0 | 100.4 | 94.8 | 93.3 | 96.7 | 88.0 | 85.6 | |
| Cost of Revenues | 39.2 | 39.7 | 40.7 | 41.5 | 38.3 | 37.2 | 39.8 | 39.3 | 46.2 | 35.9 | |
| Gross Profit | 64.5 | 64.9 | 63.9 | 64.5 | 62.1 | 57.6 | 53.5 | 57.4 | 41.8 | 49.7 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 34.2 | 28.2 | 20.4 | 19.6 | 11.6 | 10.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 127.4 | 99.2 | 99.7 | 107.7 | 58.7 | 52.8 | |
| Depreciation & Amortization | 56.6 | 56.6 | 68.0 | 56.1 | 56.5 | 45.0 | 42.8 | 40.8 | 37.0 | |
| Total Operating Expenses | 236.7 | 236.7 | 232.4 | 254.1 | 170.5 | 160.9 | 167.2 | 109.1 | 97.3 | |
| Operating Income | 21.0 | 21.0 | -1.7 | -40.8 | 32.5 | 13.6 | -24.9 | 19.6 | -4.7 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.0 | 9.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 37.9 | 35.0 | ||
| Depreciation & Amortization | 0.5 | 18.6 | 18.8 | 18.6 | 18.2 | 0.4 | 16.6 | 16.4 | 14.8 | 14.2 | ||
| Total Operating Expenses | 63.6 | 61.9 | 54.3 | 56.9 | 56.1 | 55.0 | 62.5 | 58.7 | 45.9 | 55.5 | ||
| Operating Income | 0.8 | 3.0 | 9.6 | 7.6 | 6.0 | 2.6 | -9.0 | -1.3 | -4.1 | -52.8 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 49.0 | 19.7 | 21.5 | 22.9 | 17.8 | 16.8 | 25.3 | 28.0 | 27.8 | |
| Other Expense | -13.4 | -13.4 | -15.5 | -14.4 | -13.8 | -17.0 | -25.3 | -28.8 | -0.1 | |
| IBT | 7.6 | 7.6 | -17.2 | -55.1 | 18.8 | -3.4 | -50.2 | -9.2 | -32.6 | |
| Income Tax Expense | 9.2 | 9.2 | -5.1 | 0.2 | 4.0 | 9.9 | -0.8 | -0.2 | 0.7 | |
| Net Income | -1.6 | -1.6 | -12.1 | -55.4 | 14.7 | -13.3 | -49.4 | -8.9 | -33.3 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 34.4 | 5.0 | 4.8 | 4.8 | 5.0 | 5.2 | 5.6 | 5.8 | 5.9 | 5.9 | ||
| Other Expense | -3.7 | -3.3 | -3.3 | -3.1 | -3.8 | -4.3 | -3.2 | -4.1 | -3.9 | -0.8 | ||
| IBT | -2.9 | -0.3 | 6.3 | 4.5 | 2.2 | -1.7 | -12.3 | -5.4 | -12.4 | -53.6 | ||
| Income Tax Expense | 3.0 | -1.8 | 8.2 | -0.2 | -4.4 | -0.3 | 0.3 | -0.8 | 0.1 | -4.6 | ||
| Net Income | -5.9 | 1.5 | -2.0 | 4.7 | 6.6 | -1.4 | -12.6 | -4.7 | -12.5 | -49.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.35 | $0.09 | $-0.09 | $-0.37 | $-0.06 | $-0.25 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.35 | $0.09 | $-0.09 | $-0.37 | $-0.06 | $-0.25 | |
| Shares Outstanding | 160.4 | 160.4 | 160.4 | 158.9 | 156.9 | 149.8 | 133.2 | 153.0 | 132.4 | |
| Diluted Shares Outstanding | 160.4 | 160.4 | 160.4 | 158.9 | 159.4 | 149.8 | 133.2 | 153.0 | 132.4 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.08 | $-0.31 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.08 | $-0.31 | ||
| Shares Outstanding | 160.4 | 160.4 | 160.9 | 161.0 | 160.9 | 160.6 | 160.5 | 159.5 | 159.4 | 159.2 | ||
| Diluted Shares Outstanding | 160.4 | 160.6 | 160.9 | 161.4 | 161.3 | 160.6 | 160.5 | 159.5 | 159.4 | 159.2 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 224.6 | 179.2 | 235.0 | 236.6 | 185.8 | 271.4 | 29.3 | 11.7 | |
| Short Term Investments | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 224.6 | 179.2 | 235.0 | 236.6 | 185.8 | 271.4 | 29.3 | 11.7 | |
| Accounts Receivable | 98.0 | 119.1 | 93.3 | 82.6 | 69.6 | 54.1 | 52.4 | 49.9 | |
| Inventory | -5.0 | 0.0 | 0.0 | 3.1 | 0.8 | 1.9 | 4.3 | 5.5 | |
| Other Current Assets | 14.4 | 12.6 | 12.0 | 20.0 | 18.5 | 19.2 | 1.6 | 1.8 | |
| Total Current Assets | 337.1 | 310.9 | 340.2 | 342.3 | 274.7 | 346.6 | 87.5 | 68.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 172.7 | 162.3 | 179.1 | 179.2 | 233.0 | 224.6 | 224.8 | 235.0 | 272.3 | 245.2 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.5 | 5.9 | 5.7 | |
| Total Cash & ST Investments | 172.7 | 162.3 | 179.1 | 179.2 | 233.0 | 224.6 | 224.8 | 235.0 | 272.3 | 245.2 | |
| Accounts Receivable | 98.5 | 106.3 | 105.2 | 119.1 | 106.3 | 98.0 | 89.1 | 93.3 | 83.2 | 89.1 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.5 | 13.4 | 3.0 | |
| Other Current Assets | 12.1 | 12.8 | 15.9 | 12.6 | 11.3 | 14.4 | 14.5 | 12.0 | 14.3 | 18.8 | |
| Total Current Assets | 283.3 | 281.4 | 300.2 | 310.9 | 350.6 | 337.1 | 328.5 | 340.2 | 369.8 | 353.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 16.9 | 16.0 | 12.3 | 16.8 | 15.6 | 3.9 | 4.6 | 5.4 | |
| Goodwill | 715.5 | 757.0 | 716.3 | 717.7 | 703.4 | 518.6 | 515.0 | 514.3 | |
| Intangible Assets | 463.2 | 485.2 | 487.0 | 486.8 | 511.8 | 396.4 | 428.0 | 459.6 | |
| Long-Term Investments | 0.6 | 0.0 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 2.1 | 2.0 | 1.9 | 5.6 | 2.2 | 1.2 | 1.1 | 2.4 | |
| Total Long-Term Assets | 1,202.5 | 1,264.3 | 1,222.9 | 1,230.7 | 1,237.0 | 922.8 | 949.5 | 982.6 | |
| Total Assets | 1,539.6 | 1,575.1 | 1,563.1 | 1,572.9 | 1,511.7 | 1,269.4 | 1,037.1 | 1,051.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 14.2 | 14.7 | 15.1 | 16.0 | 14.6 | 16.9 | 17.1 | 12.3 | 11.9 | 14.5 | |
| Goodwill | 773.0 | 772.3 | 764.3 | 757.0 | 718.5 | 715.5 | 715.6 | 716.3 | 673.2 | 721.9 | |
| Intangible Assets | 459.5 | 469.3 | 475.4 | 485.2 | 453.2 | 463.2 | 473.7 | 487.0 | 463.1 | 473.8 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 3.5 | 3.5 | |
| Other Long-Term Assets | 1.8 | 1.8 | 2.0 | 2.0 | 2.1 | 2.7 | 3.2 | 1.9 | 1.8 | 1.8 | |
| Total Long-Term Assets | 1,252.6 | 1,262.1 | 1,260.8 | 1,264.3 | 1,192.6 | 1,202.5 | 1,213.9 | 1,222.9 | 1,157.0 | 1,219.2 | |
| Total Assets | 1,535.9 | 1,543.4 | 1,561.0 | 1,575.1 | 1,543.2 | 1,539.6 | 1,542.4 | 1,563.1 | 1,526.8 | 1,572.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.8 | 3.5 | 5.2 | 7.5 | 7.5 | 6.4 | 4.9 | 4.9 | |
| Short-Term Debt | 7.7 | 8.3 | 7.4 | 8.0 | 3.0 | 5.0 | 4.3 | 3.4 | |
| Other Current Liabilities | 55.6 | 56.0 | 55.8 | 35.4 | 36.3 | 33.3 | 27.6 | 19.6 | |
| Current Liabilities | 129.1 | 146.1 | 130.0 | 103.2 | 92.2 | 75.3 | 63.0 | 65.5 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 3.5 | 5.5 | 5.1 | 3.5 | 2.5 | 4.8 | 3.7 | 5.2 | 5.3 | 3.8 | |
| Short-Term Debt | 3.0 | 7.3 | 3.0 | 8.3 | 3.0 | 3.0 | 3.0 | 7.4 | 7.5 | 7.7 | |
| Other Current Liabilities | 61.5 | 47.4 | 27.5 | 56.0 | 56.2 | 56.1 | 35.8 | 55.8 | 37.1 | 32.1 | |
| Current Liabilities | 135.5 | 130.4 | 108.1 | 146.1 | 122.7 | 129.1 | 100.6 | 130.0 | 105.4 | 102.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 293.7 | 303.6 | 295.2 | 300.1 | 300.0 | 294.4 | 397.1 | 404.8 | |
| Capital Leases | 11.2 | 16.5 | 7.0 | 15.1 | 8.3 | 0.6 | 0.0 | 0.3 | |
| Def. Tax Liability | 37.5 | 40.4 | 50.8 | 65.0 | 76.1 | 75.9 | 82.2 | 85.7 | |
| Total Liabilities | 496.2 | 516.4 | 516.3 | 493.3 | 469.9 | 447.3 | 545.0 | 558.7 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 299.5 | 300.5 | 301.6 | 303.6 | 303.5 | 304.8 | 299.4 | 295.2 | 295.9 | 297.4 | |
| Capital Leases | 9.0 | 9.4 | 9.8 | 16.5 | 10.4 | 11.2 | 11.6 | 7.0 | 11.7 | 8.3 | |
| Def. Tax Liability | 32.6 | 36.6 | 40.9 | 40.4 | 0.0 | 38.8 | 47.6 | 50.8 | 46.4 | 54.7 | |
| Total Liabilities | 471.0 | 472.9 | 476.7 | 516.4 | 489.8 | 496.2 | 488.0 | 516.3 | 475.1 | 475.0 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.3 | 1.3 | |
| Retained Earnings | -133.5 | -128.3 | -116.2 | -60.9 | -75.6 | -62.3 | -12.9 | -14.4 | |
| Comprehensive Income | -8.3 | -13.4 | -7.6 | -8.2 | -3.9 | -1.6 | -5.5 | -1.6 | |
| Total Common Equity | 1,043.4 | 1,058.7 | 1,046.8 | 1,079.7 | 1,041.8 | 822.1 | 492.0 | 492.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | |
| Retained Earnings | -124.0 | -125.5 | -123.5 | -128.3 | -134.9 | -133.5 | -120.9 | -116.2 | -103.8 | -54.8 | |
| Comprehensive Income | 1.9 | 4.9 | -5.3 | -13.4 | -5.0 | -8.3 | -7.0 | -7.6 | -7.7 | -3.2 | |
| Total Common Equity | 1,064.8 | 1,070.6 | 1,084.3 | 1,058.7 | 1,053.4 | 1,043.4 | 1,054.4 | 1,046.8 | 1,051.8 | 1,097.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 312.6 | 311.9 | 298.2 | 308.1 | 303.0 | 299.4 | 401.4 | 408.3 | |
| Book Value | 1,043.4 | 1,058.7 | 1,046.8 | 1,079.7 | 1,041.8 | 822.1 | 492.0 | 492.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,064.8 | 1,070.6 | 1,084.3 | 1,058.7 | 1,053.4 | 1,043.4 | 1,054.4 | 1,046.8 | 1,051.8 | 1,097.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -78.7 | -1.6 | -12.1 | -55.4 | 14.7 | -13.3 | -49.4 | -8.9 | -33.3 | |
| Depreciation & Amortization | 62.0 | 75.2 | 68.0 | 56.1 | 52.5 | 45.1 | 42.8 | 41.6 | 37.0 | |
| Stock-Based Compensation | 35.0 | 33.1 | 34.8 | 28.3 | 30.3 | 29.5 | 64.5 | 1.7 | 1.7 | |
| Change Working Capital | -9.1 | -0.1 | -8.2 | -4.7 | 3.7 | -2.9 | -6.7 | 8.7 | 8.3 | |
| Change In Accounts Receivable | -6.2 | 0.4 | -16.2 | 0.2 | -15.0 | -10.1 | -3.9 | -1.5 | -2.0 | |
| Change In Accounts Payable | -5.6 | 4.4 | -4.8 | -5.6 | 5.3 | 1.1 | 2.4 | 10.0 | -6.4 | |
| Change In Inventories | 5.9 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | -8.3 | -1.8 | -2.6 | |
| Other Non-cash Items | 179.1 | -1.9 | 10.6 | 75.0 | 2.8 | 3.2 | 1.5 | 1.7 | 1.4 | |
| Cash from Operations | 68.9 | 0.0 | 0.0 | 82.8 | 92.5 | 60.4 | 44.8 | 38.0 | 11.6 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.0 | 1.5 | -2.0 | 4.7 | 6.6 | -1.4 | -12.6 | -4.7 | -12.5 | -49.0 | |
| Depreciation & Amortization | -0.1 | 18.8 | 18.8 | 18.6 | 18.2 | 16.9 | 17.0 | 16.8 | 14.8 | 14.2 | |
| Stock-Based Compensation | 0.0 | 9.6 | 8.2 | 7.1 | 7.7 | 8.2 | 9.8 | 9.1 | 7.5 | 8.6 | |
| Change Working Capital | 8.1 | 3.6 | 10.7 | -22.7 | 13.9 | -6.5 | -10.0 | 3.1 | -2.4 | 7.9 | |
| Change In Accounts Receivable | -13.0 | 7.9 | -3.3 | 8.7 | -5.3 | -4.4 | -10.2 | 3.6 | -6.3 | 6.7 | |
| Change In Accounts Payable | 11.0 | 0.0 | 13.9 | -27.8 | 0.0 | 0.0 | 0.0 | 0.0 | -4.0 | 6.8 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.6 | -6.8 | |
| Other Non-cash Items | 26.4 | -1.1 | -5.5 | -0.9 | 3.1 | -0.2 | 5.6 | -20.0 | 13.9 | 57.9 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.3 | 31.4 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -18.1 | -1.8 | -1.6 | -1.8 | -12.5 | -8.9 | -7.9 | -9.5 | -11.5 | |
| Acquisitions | -65.3 | -13.2 | -91.3 | -64.2 | -15.3 | -261.0 | -0.7 | 0.0 | -62.4 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -15.9 | 0.0 | 0.0 | -13.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -74.8 | 0.0 | 0.0 | -79.6 | -27.8 | -269.9 | -8.6 | -9.5 | -73.9 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 5.2 | -0.2 | 0.1 | -5.8 | -5.8 | -0.2 | -0.4 | -0.6 | -4.4 | -4.0 | |
| Acquisitions | -13.2 | 0.0 | 0.0 | 0.0 | -91.3 | 0.0 | 0.0 | 0.0 | -56.7 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.5 | -3.7 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -61.0 | -4.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -7.4 | 0.0 | 0.0 | -3.0 | -3.3 | -4.0 | -124.2 | -8.4 | -9.0 | |
| Debt Issued | 19.5 | 311.9 | 13.7 | -6.9 | 8.4 | 7.6 | 22.2 | 1.5 | 417.3 | |
| Issuance of Common Stock | 3.7 | 0.0 | 0.0 | 0.0 | 0.0 | 133.4 | 316.6 | 0.7 | 1.1 | |
| Repurchase of Common Stock | -8.7 | -42.6 | -8.7 | -6.4 | 0.0 | 0.0 | -1.1 | -0.7 | -1.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -19.9 | -0.7 | -75.0 | |
| Other Financing Activities | -19.1 | 0.0 | 0.0 | -6.4 | -4.1 | -6.0 | 36.9 | 0.7 | 141.3 | |
| Cash from Financing | -16.3 | 0.0 | 0.0 | -9.4 | -7.4 | 123.4 | 208.2 | -8.5 | 57.3 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -0.8 | |
| Debt Issued | 302.5 | -5.4 | 3.2 | -7.3 | 5.4 | -1.4 | 5.4 | 4.2 | -4.4 | 3.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -3.9 | -13.7 | -25.0 | 0.0 | 0.0 | -0.1 | -7.1 | -0.9 | -0.5 | -0.2 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | -0.2 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.3 | -0.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -23.6 | 10.2 | -55.8 | -4.7 | 53.1 | -86.7 | 243.5 | 17.6 | -6.4 | |
| Closing Cash Balance | 224.6 | 189.4 | 179.2 | 235.0 | 239.7 | 186.6 | 273.3 | 29.8 | 12.2 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 16.7 | 10.4 | -16.8 | -0.1 | -53.8 | 8.4 | -0.2 | -10.2 | -37.4 | 24.1 | |
| Closing Cash Balance | 189.4 | 172.7 | 162.3 | 179.1 | 179.2 | 233.0 | 224.6 | 224.8 | 235.0 | 272.3 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 50.7 | 94.6 | 78.8 | 67.4 | 80.0 | 51.5 | 36.9 | 28.5 | 0.1 | |
| Real Free Cash Flow | 15.7 | 61.5 | 44.1 | 39.1 | 49.7 | 22.0 | -27.6 | 26.8 | -1.6 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 27.8 | 32.1 | 17.9 | 11.6 | 43.5 | 16.8 | 9.4 | 3.7 | 19.0 | 27.4 | |
| Real Free Cash Flow | 27.8 | 22.5 | 9.7 | 4.5 | 35.8 | 8.6 | -0.4 | -5.4 | 11.5 | 18.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -618.4 | -196 | 120.8 |
| P/S | 2.4 | 9.5 | 9.7 |
| P/B | 0.9 | 3 | 738.2 |
| P/FCF | 15.3 | 37.4 | 111.3 |
| Market cap | $1.4 | $2.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 19.7 % | 18.6 % | 0 % |
| Debt to Income | -18965.9 % | -2293.4 % | 0 % |
| Debt to Free cash flow | 469 % | 36.1 % | 0 % |
| Interest expense percentage | 233 % | 19.9 % | 18.1 % |
| Current ratio | 2.1 | 3.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -0.1 % | -2.1 % | 0 % |
| ROA | -0.1 % | -1.4 % | 0 % |
| CapEx to Revenue | 2.8 % | 3.3 % | 2.4 % |
| RaD to Revenue | 0 % | 7.9 % | 0 % |
| ROEM | 270,917.2 | 126894.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 58.1 % | 58.1 % | 89.7 % |
| Operating margin | 7.2 % | 1.1 % | 37.4 % |
| Net margin | 2.6 % | -7.1 % | 37.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 160.6 mil | 149.2 mil |
| Employee count | 1.5 tis | 1.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
